Delivery Order HHSN261201200031I-HHSN26100004
Award Date
7/15/14
Potential Completion Date
3/14/15
Potential Value
$152K
Federal Agency
National Cancer Institute
Awardee
University Of Arizona
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Tucson, AZ 85719, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $580,503.00 delivery order award under the Cancer Prevention Agent Development Program 2012-2017 indefinite delivery contract issued by the National Cancer Institute, a component of the U.S. Department of Health and Human Services. The order was awarded to the University of Arizona, doing business as the Arizona Board of Regents, for research and development services to support core infrastructure for the agency's cancer prevention agent development efforts. The work will be...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Delivery Order contract to the University of Arizona, doing business as the Arizona Board of Regents, to provide core infrastructure support for the Cancer Prevention Agent Development Program. The $1,535,496.00 contract has a performance period ending on September 22, 2023 and does not utilize a set-aside designation. This Delivery Order is part of the larger Cancer Prevention Agent...
This federal contract award, valued at $226,000.00, was issued by the Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences to the University of Arizona, doing business as the Arizona Board of Regents. The contract is for a "TAS TEXTING TEENS ABOUT WELLNESS & SKIN CANCER RESEACH PROJECT WITH NLM AND AND THE ARIZONA BOARD OF REGENTS, UNIVERSITY OF ARIZONA, ARIZONA CANCER CENTER" and has a completion date of July 14,...
This is a federal contract award to the University of Arizona, doing business as the Arizona Board of Regents, by the National Cancer Institute (NCI). The $796,585.45 contract is for a clinical study of Avmacol, a product aimed at detoxifying tobacco carcinogens in heavy smokers. This award is part of the NCI's Cancer Prevention Agent Development Program, which funds early-phase clinical research. The contract is a delivery order under a master Indefinite Delivery/Indefinite Quantity (IDIQ)...
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to the University of Arizona. The contract, valued at $812,957.75, is for a delivery order under the Cancer Prevention Agent Development Program 2012-2017 master IDIQ contract. The purpose of the award is for the "M4OC-PREVENT: METFORMIN FOR ORAL CANCER PREVENTION" project, which is part of the NCI's Cancer Prevention Agent Development...
This is a federal contract award to the University of Arizona, doing business as the Arizona Board of Regents, by the National Cancer Institute (NCI) under the Cancer Prevention Agent Development Program 2012-2017. The award has a ceiling value of $2,924,327.60 and is for research and development services related to the core infrastructure support for the NCI's cancer prevention agent development program's early phase clinical research. The contract is a delivery order and does not have a...
This is a delivery order under the Cancer Prevention Agent Development Program 2012-2017 IDIQ contract, awarded by the National Cancer Institute to the University of Arizona for a value of $1,027,142.83. The contract is for the development of topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) grades 2-3, with a period of performance through September 15, 2023. The contract does not have a set-aside designation. The University of Arizona has subcontracted a portion of...
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), Infections and Immunoepidemiology Branch (IIB) awarded a firm-fixed-price contract to the University of Arizona in the amount of $310,995.00 to provide pulling, selecting, aliquoting, and shipping of up to 13,000 samples collected from participants in the NCI's ANCHOR (ANal Cancer/HSIL Outcomes Research) study, as well as...
This is a prime contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Arizona, doing business as the Arizona Board of Regents. The $13,812,898.37 contract is for biomedical research services and is not designated as a set-aside award. The University of Arizona is providing a range of specialized research capabilities to NIAID, including expertise in areas such as astrophysics, biomedical...
This is a prime contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California Irvine (UC Irvine) for Phase I and II clinical trials of cancer chemopreventive agents. The $13,886,589.26 definitive contract does not have a set-aside designation, as UC Irvine was selected based on its extensive research capabilities and expertise in biomedical sciences. The contract supports the development of novel cancer prevention...